Exercise and Breast Cancer During COVID-19 Pandemic
Not Applicable
Recruiting
- Conditions
- Breast Cancer.Malignant neoplasm of breast
- Registration Number
- IRCT20210617051606N4
- Lead Sponsor
- Razi University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 28
Inclusion Criteria
Diagnosed with breast cancer by a specialist
No signs of relapse or tumor metastasis
No less than 3 months and more than 5 years passed from the last cancer-specific treatment (chemotherapy or radiotherapy)
Not participating in regular exercise training within last 6 months
Exclusion Criteria
Cardiovascular and pulmonary diseases
Alcohol and other kinds of drug addiction
Musculoskeletal disorder
Pregnancy
Refusal to give informed consent
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in serum levels of Cortisol. Timepoint: Before starting the intervention, and 16 weeks after starting the intervention. Method of measurement: By the use of blood sample and ELISA method.;Change in quality of life. Timepoint: Before starting the intervention, and 16 weeks after starting the intervention. Method of measurement: Cancer quality of life questionnaire (EORTC-QOQ-C30).;Changes in cancer-related fatigue. Timepoint: Before starting the intervention, and 16 weeks after starting the intervention. Method of measurement: By the use of Functional Assessment of Chronic Illness Therapy- Fatigue Scale (Version 4).
- Secondary Outcome Measures
Name Time Method Changes in body image. Timepoint: Before starting the intervention, and 16 weeks after starting the intervention. Method of measurement: By the use of standard cancer-specific 10-item body image scale.;Changes in cardiovascular endurance. Timepoint: Before starting the intervention, and 16 weeks after starting the intervention. Method of measurement: By the use of sub-maximal 1-mile (1600 m) walking Rockport test.;Changes in body composition. Timepoint: Before starting the intervention, and 16 weeks after starting the intervention. Method of measurement: By the use of bioelectrical impedance analysis.;Changes in cognitive function. Timepoint: Before starting the intervention, and 16 weeks after starting the intervention. Method of measurement: By the use of Cognitive Failure Questionnaire (25 items).